metyrapone has been researched along with Anemia, Aplastic in 1 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
Excerpt | Relevance | Reference |
---|---|---|
"Three children with Fanconi's anemia belonging to a family where 6 children had the disease were investigated." | 1.25 | Fanconi's anemia. II. Are multiple endocrine insufficiencies a substantial part of the disease? ( Prindull, G; Stubbe, P, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stubbe, P | 1 |
Prindull, G | 1 |
1 other study available for metyrapone and Anemia, Aplastic
Article | Year |
---|---|
Fanconi's anemia. II. Are multiple endocrine insufficiencies a substantial part of the disease?
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Anemia, Aplastic; Arginine; Blood Glucose; Body Height; | 1975 |